Skip to main content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

Modifiable cardiovascular risk factors in adults aged 40–79 years in Germany with and without prior coronary heart disease or stroke

  • 1Email author,
  • 1,
  • 1, 2,
  • 1, 2,
  • 1,
  • 2, 3, 4, 5 and
  • 1, 2
BMC Public Health201515:701

https://doi.org/10.1186/s12889-015-1929-5

©  Truthmann et al. 2015

  • Received: 6 January 2015
  • Accepted: 11 June 2015
  • Published:
Open Peer Review reports

Abstract

Background

Control of modifiable cardiovascular disease (CVD) risk factors has substantially reduced CVD mortality, but risk factor levels in populations may change and need continuous monitoring. This study aims to provide current estimates of the prevalence of these risk factors in Germany according to sex and history of coronary heart disease (CHD) or stroke.

Methods

The analyses were based on data from the German Health Interview and Examination Survey for Adults (DEGS1; age 40–79 years, n = 5101), which is a cross-sectional population-based examination survey. CVD risk factors were defined according to recommendations in the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice 2012.

Results

The mean age was 57 years and 52 % were female; 493 participants had prior CHD and 163 participants a prior stroke. The overall prevalence of behavioural risk factors ranged from 17.9 % for high risk alcohol consumption to 90 % for low vegetable intake. Blood pressure ≥ 140/90 mmHg was found in 21 % and 69 % had total cholesterol ≥ 5.0 mmol/l. Only 16 % met the targets for five behavioural factors combined (smoking, physical activity, fruit intake, alcohol intake and obesity), 13 % of those with and 16 % of those without CHD or stroke. The prevalences of most behavioural risk factors were higher among men compared to women.

Conclusions

There is a high prevention potential from modifiable cardiovascular risk factors in the general population aged 40–79 years in Germany and among those with prior CHD or stroke. Risk factors are often co-occurring, are interrelated and require combined educational, behavioral, medical and policy approaches.

Keywords

  • Coronary heart disease
  • Stroke
  • Prevention
  • Risk factors

Background

Cardiovascular disease (CVD) is the most common cause of death before the age of 65 in Europe [1]. However, a substantial proportion of these deaths may be preventable through changes in lifestyle [2]. The European Guidelines on cardiovascular disease prevention in clinical practice 2012 (ESC 2012) [3] made the following key recommendations to lower CVD risk: quit smoking, increase physical activity, eat a healthy diet, limit alcohol consumption, reduce body weight, reduce blood pressure (BP) and control blood lipids. Men and women with established CVD are at very high risk for future events and prompt interventions on risk factors are recommended. However, CVD risk factors often remain uncontrolled [4, 5], and up-to-date data on the prevention potential of modifiable risk factors in the general population as well as in high-risk groups are difficult to obtain.

The aim of this cross-sectional study is to contribute to the debate on CVD prevention by providing up-to-date estimates of CVD risk factor proportions of the principal modifiable CVD risk factors in adults aged 40–79 years in Germany with data from the nationwide population-based German Health Interview and Examination Survey for Adults (DEGS1) [6]. In addition, the study presents risk factor prevalences among persons with and without prior coronary heart disease (CHD) or stroke.

Methods

Study design and sample

The first wave of the German Health Interview and Examination Survey for Adults (DEGS1) was conducted in 2008–2011 with the aim to obtain comprehensive information about the health of the residential population aged 18–79 years living in Germany. Design and methods were described in detail elsewhere [6–8]. The survey comprises 8151 men and women who live in Germany, including 4192 first-time participants and 3959 persons who already participated in the German National Health Interview and Examination Survey 1998 (GNHIES98) [8]. Exclusion criteria for the present analysis are presented in Fig. 1 resulting in a final study sample of 5101 participants (2436 men, 2665 women).
Fig. 1
Fig. 1

Exclusion criteria. CHD: Coronary heart disease

The DEGS1 study was approved by the Federal and State Commissioners for Data Protection and the Charité - Universitätsmedizin Berlin ethics committee (No. EA2/047/08). All participants provided written informed consent prior to the interview and examination.

Data collection and study variables

The modifiable risk factors were defined according to recommendations of the ESC 2012 guideline [3]. As part of a general self-administered health questionnaire, daily smoking was assessed with several questions. Physical activity within a usual week was also assessed within this questionnaire and defined as low when < 2.5 h physical activity/week [9] and physical inactive when no physical activity was reported. A semi-quantitative self-administered food frequency questionnaire was used to assess the frequency and portion size of 53 food items for a reference period of the past four weeks. The number of servings of fruit (fresh and cooked) and vegetable (fresh and cooked vegetable, legumes) and servings of fish (cold fish and fish as a hot meal) per day were calculated by combining the frequency of consumption and the usual portion size. Low fruit intake was defined as < 2 portions fruit per day, low vegetable intake as < 2 portions vegetable per day and low fish intake as < 1 portion fish per week. Quantity of alcohol intake was calculated by summing the alcohol content of consumed beer, non-alcoholic beer (still containing minute alcohol amounts), wine, spirits [10] and cocktails (assuming one cocktail to contain 15.0 g of alcohol [11]). High alcohol consumption was defined as > 10 g alcohol per day in women and > 20 g alcohol per day in men. Since zero alcohol consumption has been related to increased cardiovascular risk and mortality, a separate category was defined as alcohol intake of 0 g/day [3]. Body weight was measured with an electronic scale and body height was measured using a portable stadiometer. The body mass index (BMI) was calculated as BMI [kg/m2] = body weight [kg]/body height2 [m]. A BMI ≥ 25 kg/m2 was defined as overweight and a BMI ≥ 30 kg/m2 was defined as obesity [12]. Three sitting blood pressure (BP) measurements were taken after a five-minute rest on the right arm following a standardized protocol with an automated oscillometric device (Datascope Accutorr Plus) and the prevalence of BP above ≥ 140 mmHg systolic or above ≥ 90 mmHg diastolic was determined using the mean of the second and third BP measurements. Total cholesterol (TC) and high density lipoprotein cholesterol (HDL) were measured using an enzymatic assay (Architect ci8200, Abbott, Germany). Elevated TC was defined as a value ≥ 5.0 mmol/l (190 mg/dl) and an additional cut-off of 6.2 mmol/l (240 mg/dl) was included based on previous guidelines [13]. Non-HDL was calculated by subtracting HDL from TC. Elevated non-HDL was defined as ≥ 3.8 mmol/l among participants without prior CHD or stroke and ≥ 2.6 mmol/l among those with prior CHD or stroke. Previous diagnoses of CHD, stroke, hypertension and dyslipidaemia were assessed in a standardized physician interview. Medications taken in the previous seven days were coded according to the Anatomical Therapeutic Chemical (ATC) classification system. Medications from ATC-group C10 were counted as lipid-lowering when dyslipidaemia was known. Similarly, medications from ATC groups C03, C07, C08, C09 and C02 were defined as antihypertensive in those with known hypertension.

Analysis

For the descriptive analyses percentages and 95 % confidence intervals were calculated. In order to account for the unequal sampling probabilities related to the sampling design and nonresponse, statistical analyses were weighted using a weighting factor [8] and the complex survey sampling was taken into account using complex samples procedures in SPSS version 20.0 (SPSS Inc., Chicago, Illinois, USA). P values less than 0.05 were considered statistically significant. The analyses were stratified for prior CHD or stroke, sex and age. Furthermore, the prevalences of cardiovascular risk factors were calculated according to obesity status, BP level and TC level group. For analysis of behavioural risk factor combinations, we considered five categories represented by one indicator each: daily smoking, physical activity <2.5 h/week, < 2 portions of fruit/day, alcohol intake >10 g/day in women or >20 g/day in men, and BMI ≥ 30 kg/m2.

Results

The mean age of the study population was 57 years and 52 % were female. The prevalence of CHD was 9 % (95 % CI 8–10) and the prevalence of stroke was 3 % (95 % CI 2–3). The prevalence of prior CHD or stroke was 11 % (95 % CI 10–12). The mean age of the group with CHD or stroke was 67 years and 35 % were female. Table 1 shows the distribution of cardiovascular risk factors for the overall sample and for participants with and without prior CHD or stroke separately. The overall prevalence of behavioral risk factors ranged from 18 % for high risk alcohol consumption and 20 % for daily smoking to 82 % for low physical activity and 90 % for low vegetable intake. BP ≥ 140/90 mmHg was found in 21 % and 69 % had TC ≥ 5.0 mmol/l (including 27 % with TC ≥ 6.2 mmol/l).
Table 1

Prevalence of cardiovascular risk factors (95 % confidence interval) among adults aged 40–79 years

Risk factor

Total (N = 5101)

No CHD or stroke (N = 4489)

CHD or stroke (N = 612)

P

Daily smoking

19.8 (18–21.7)

20.2 (18.3–22.2)

16.5 (12.4–21.6)

0.200

<2.5 h physical activity/week

82.4 (80.9–83.7)

82.2 (80.7–83.6)

84.1 (79.9–87.6)

0.400

Physically inactive (no physical activity in average week)

34.2 (32.3–36.4)

32.4 (30.3–34.6)

49.8 (44.4–55.3)

<0.001

<2 portions fruit/day

66.1 (64.3–67.8)

65.8 (63.9–67.7)

68.1 (63–72.8)

0.400

<2 portions vegetable/day

90.4 (89.2–91.5)

90.1 (88.8–91.3)

92.8 (89.3–95.2)

0.100

<1 portion fish/week

67.3 (65.5–69.1)

66.8 (64.9–68.7)

71.6 (66.5–76.2)

0.100

Alcohol intake > 10 g/day (women) or 20 g/day (men)

17.9 (16.5–19.4)

18 (16.7–19.5)

16.7 (12.9–21.4)

0.600

Alcohol intake = 0 g/day

12.7 (11.3–14.3)

12.4 (10.8–14.2)

15.2 (11.7–19.5)

0.200

Overweight (BMI ≥ 25 kg/m2)

69.9 (68.2–71.5)

68 (66.3–69.8)

85.1 (81.2–88.3)

<0.001

Obesity (BMI ≥ 30 kg/m2)

28.4 (26.6–30.2)

26.5 (24.8–28.3)

43.1 (37.4–48.9)

<0.001

BP ≥ 140/90 mmHg

20.6 (18.9–22.4)

20.7 (18.9–22.5)

20 (16.1–24.5)

0.700

Proportion unawarea among those with BP ≥ 140/90 mmHg

33.5 (30.2–37)

36 (32.5–39.7)

12.1 (6.6–21.3)

<0.001

Proportion treated and awareb among those with BP ≥ 140/90 mmHg

45.4 (41.9–49)

42.5 (38.8–46.3)

70.6 (59.2–79.9)

<0.001

Elevated TC (≥5.0 mmol/l)

68.8 (66.5–71)

71.2 (68.9–73.5)

48.9 (43.6–54.1)

<0.001

Highly elevated TC (≥6.2 mmol/l)

24.7 (22.9–26.6)

25.9 (23.9–27.9)

15.2 (11.6–19.7)

<0.001

Proportion unawarea among those with TC ≥ 5.0 mmol/l

57.5 (55.3–59.7)

59.4 (57–61.7)

35.0 (28.6–42)

<0.001

Proportion treated and awareb among those with TC ≥ 5.0 mmol/l

9.1 (8–10.3)

7.5 (6.4–8.7)

28.3 (22.4–35.1)

<0.001

P values less than 0.05 were considered statistically significant (bold)

BMI body mass index, BP blood pressure, CHD coronary heart disease, TC total cholesterol

adefined as reported diagnosis of hypertension or dyslipidaemia

bdefined as reported diagnosis of hypertension or dyslipidaemia in combination with reported use of antihypertensive or lipid-lowering drugs, respectively

The prevalence of behavioural risk factors (daily smoking, insufficient physical activity, insufficient fruit, vegetable and fish intake, high alcohol intake) was similar in participants with and without prior CHD or stroke. Participants with CHD or stroke were significantly more likely to be physically inactive, overweight and/or obese. Prevalence of BP ≥ 140/90 mmHg was similar in both groups. Participants with prior CHD or stroke were less likely to have elevated TC, but had a higher prevalence of elevated non-HDL (≥2.6 mmol/l; see Additional file 1, Table S1) compared to participants without prior CHD or stroke (≥3.8 mmol/l). Also, participants with prior CHD or stroke with BP ≥ 140/90 mmHg or elevated TC were less likely to be unaware of their hypertension or hyperlipidaemia, respectively and those aware were more likely to be treated.

The proportions of risk factors stratified for men and women are shown in Table 2. Compared to women, the prevalence of smoking, low fruit, vegetable and fish intake, high alcohol intake, overweight, BP ≥ 140/90 mmHg and non-HDL ≥ target was higher among men. In contrast, women were more often physically inactive and exceeded more often both cut offs for TC.
Table 2

Prevalence of cardiovascular risk factors (95 % confidence interval) among men and women aged 40–79 years

Risk factor

Men

Women

Total (N = 2436)

No CHD or stroke (N = 2040)

CHD or Stroke (N = 396)

P

Total (N = 2665)

No CHD or stroke (N = 2449)

CHD or Stroke (N = 216)

P

Daily smoking

21.6

22.4

16.4

0.100

18

18.2

16.7

0.700

(19.1–24.3)

(19.5–25.6)

(11.5–22.9)

 

(16.1–20.2)

(16.2–20.3)

(10.2–26)

 

<2.5 h physical activity/week

80

79.6

82.7

0.300

84.7

84.5

86.4

0.600

(77.8–82.1)

(77.2–81.8)

(76.9–87.3)

 

(82.8–86.4)

(82.5–86.3)

(79–91.5)

 

Physically inactive (no physical activity in average week)

32.3

29.8

48.1

<0.001

36.2

34.8

52.9

<0.001

(29.7–35.1)

(27–32.7)

(40.8–55.5)

 

(33.6–39)

(32.1–37.7)

(44–61.7)

 

<2 portions fruit/day

71

71.5

67.7

0.300

61.3

60.7

68.8

0.100

(68.5–73.3)

(68.9–74)

(60.9–73.9)

 

(58.9–63.7)

(58.2–63.1)

(60.8–75.8)

 

<2 portions vegetable/day

93.9

93.8

93.7

0.900

87

86.7

90.7

0.200

(92.4–95.1)

(92.7–95.1)

(88.8–96.9)

 

(85–88.8)

(84.5–88.6)

(85.1–94.3)

 

<1 portions fish/week

66.5

64.8

70.2

0.100

69.1

68.6

74

0.200

(63.1–67.9)

(62.2–67.3)

(64.1–75.6)

 

(66.5–71.5)

(66–71.2)

(65.7–80.8)

 

Alcohol intake > 10 g/day (women) or 20 g/day (men)

21.4

21.3

21.9

0.800

14.4

15

7.6

0.100

(19.2–23.6)

(19.1–23.6)

(16.5–28.5)

 

(12.7–16.3)

(13.2–16.9)

(3.5–15.6)

 

Alcohol intake = 0 g/day

8

8

8.5

0.800

17.4

16.6

27.1

0.005

(6.6–9.6)

(6.3–10)

(5.1–13.7)

 

(15.3–19.8)

(14.4–19.2)

(20.2–35.3)

 

Overweight (BMI ≥ 25 kg/m2)

77.6

76.2

85.9

0.001

62.4

60.5

83.6

<0.001

(75.4–79.6)

(73.8–78.5)

(81.1–89.7)

 

(60–64.8)

(58–63)

(77.2–88.5)

 

Obesity (BMI ≥ 30 kg/m2)

27.8

25.7

40.3

<0.001

28.9

27.2

47.8

<0.001

(25.2–30.6)

(23.2–28.5)

(33.2–47.8)

 

(26.5–31.4)

(24.8–29.8)

(38.8–57)

 

BP ≥ 140/90 mmHg

23.4

23.8

20.9

0.300

17.8

17.8

18.4

0.800

(21.1–25.9)

(21.4–26.4)

(16.1–26.7)

 

(15.8–20.1)

(15.7–20.1)

(12.4–26.2)

 

Proportion of unawarea among those with BP ≥ 140/90 mmHg

36.1

39.6

10.3

<0.001

30.3

31.6

15.6

0.100

(31.3–41.1)

(34.6–44.9)

(4.2–23.1)

 

(25.5–35.5)

(26.5–37.2)

(6.7–32.3)

 

Proportion treated and awareb among those with BP ≥ 140/90 mmHg

40.5

36

73.2

<0.001

51.7

50.4

65.6

0.100

(35.3–46.1)

(30.6–41.8)

(58–84.3)

 

(46.6–56.8)

(45.3–55.6)

(46.9–80.5)

 

Elevated total cholesterol (TC ≥ 5.0 mmol/l)

65.2

68.8

43.6

<0.001

72.3

73.4

59.4

<0.001

(62.1–68.2)

(65.6–71.9)

(33.6–49.5)

 

(69.7–74.8)

(70.7–76)

(50.9–67.3)

 

Highly elevated TC (≥6.2 mmol/l)

22.8

24.5

12.6

0.001

26.5

27.1

19.7

0.100

(20.4–25.4)

(21.9–27.3)

(8.3–18.6)

 

(24.1–29.1)

(24.6–29.8)

(13.6–27.8)

 

Proportion of unawarea among those with TC ≥ 5.0 mmol/l

57.3

59.4

36.5

<0.001

57.7

59.4

33.1

<0.001

(53.9–60.6)

(55.7–62.9)

(27.2–47.1)

 

(54.7–60.7)

(56.3–62.5)

(23.6–44.2)

 

Proportion treated and awareb among those with TC ≥ 5.0 mmol/l

8.9

6.8

29.7

<0.001

9.3

8.1

26.6

<0.001

(7.3–10.7)

(5.4–8.4)

(21.1–40.1)

 

(7.7–11.2)

(6.5–10)

(18.5–36.7)

 

P values less than 0.05 were considered statistically significant (bold)

BMI body mass index, BP blood pressure, CHD coronary heart disease, TC total cholesterol

adefined as reported diagnosis of hypertension or dyslipidaemia

bdefined as reported diagnosis of hypertension or dyslipidaemia in combination with reported use of antihypertensive or lipid-lowering drugs, respectively

Age-group specific analyses revealed higher or equal proportions of most unfavourable risk factor levels in the older age group (see Additional file 1). As exceptions, smoking prevalence and proportion of unaware persons with elevated TC (≥5.0 mmol/l) were lower in older men and women and high alcohol intake was less frequent in older women.

The risk factor prevalences stratified by obesity group, BP target and TC target groups are presented in Additional file 2. Compared to non-obese participants, prevalence of BP ≥ 140/90 mmHg and zero alcohol consumption was higher among obese participants. In contrast, non-obese participants were more often physically inactive and exceeded more often the recommended alcohol intake. Compared to participants with BP < 140/90 mmHg prevalence of alcohol intake, TC ≥ 5.0 mmol/l, overweight and obesity was higher, and the prevalence of smoking was lower among the group with BP ≥ 140/90 mmHg. Except for BP, no difference could be observed between the TC target groups.

Figure 2 shows the combination of five behavioural risk factors. Only 15 % had none of these risk factors, 39 % had one risk factor, and 45 % had two or more risk factors. More women than men had no risk factor (12 % (95 % CI 11–14) vs. 19 % (95 % CI 17–21)). More than half of the CHD or stroke group and about 44 % of the group without prior CHD or stroke had two or more risk factors. Women with CHD or stroke more often had a combination of two or more behavioural risk factors compared to women without CHD or stroke (52 % (95 % CI 44-61) vs. 39 % (95 % CI 37-42)).
Fig. 2
Fig. 2

Combination of five behavioural risk factors (%) in adults aged 40–79 years with and without coronary heart disease (CHD) and stroke. The prevalences were stratified for sex and group with and without coronary heart disease (CHD) and stroke. The following behavioural risk factor categories were included: daily smoking, physical activity <2.5 h/week, < 2 portions of fruit/day, alcohol intake >10 g/day in women or >20 g/day in men, BMI ≥ 30 kg/m2

Discussion

The results of this cross-sectional analysis of modifiable cardiovascular risk factors in adults in Germany suggest that, for the vast majority of adults in Germany, there is a high prevention potential for all of the behavioural risk factors investigated in this study: daily smoking, insufficient fruit, vegetable and fish consumption, high alcohol intake, insufficient physical activity and overweight. Almost 85 % of adults aged 40–79 years have at least one of these risk factors, with 45 % having a combination of two or more risk factors.

Studies on CVD risk factors in different countries are often difficult to compare due to differences in the specific combinations and definitions of the risk factors that were assessed. In the United States adherence to five healthy behavioural factors (including fruit and vegetable consumption, regular exercise, healthy weight, alcohol consumption and smoking) in 40 to 74 year olds was as low as 8 % in 2006 and had decreased from 15 % in 1988 [14]. A recent analysis from Italy on six cardiovascular risk factors (smoking, low fruit/vegetable consumption, obesity/overweight, hypertension, dyslipidaemia and diabetes) found that 90 % of the study population had more than one and 84 % had between two and five risk factors [15].

For BP and TC, we report prevalences of elevated, i.e., uncontrolled values as measured in our study. These prevalences do not include controlled hypertension or controlled hypercholesterolemia. It is encouraging that the target BP (<140 mmHg systolic and < 90 mmHg diastolic) was reached by almost 80 % of the participants but this proportion may be lower among severely ill patient groups. For comparison, in the SHARE survey the more stringent targets of < 140/90 mmHg in general and < 130/80 mmHg for patients with co-morbidities or high CV risk were reached by less than 60 % of general practice patients and by less than half of patients treated by cardiologists/internists [16]. The joint ESC 2012 guideline targets for hyperlipidaemia are mainly based on low-density lipoprotein (LDL) levels. We used TC and non-HDL since fasting level LDL data were not available for a sufficient number of participants. However, TC and non-HDL are established markers for increased cardiovascular risk and are independent of fasting time [17, 18]. The TC targets were more often reached by the CHD or stroke group than by the group without CHD or stroke, which is similar to previous findings [19] and most likely reflects more intensive lipid-lowering therapy among people with prior CHD or stroke. However, almost 90 % of the CHD or stroke group exceeded the stringent non-HDL target.

Except for physical inactivity, prevalence of behavioural risk factors was higher among men. Other studies found similar results concerning physical activity [20], smoking [5, 21], BMI [15] and fruit and vegetable intake [15]. Possible reasons include gender-specific cultural norms relating to lifestyle [22] and gender-specific responses to lifestyle. Higher prevalences for most modifiable risk factors were found among the age group 60–79 years compared to the younger group. This indicates the need for preventive interventions at early life stages, because the risk of CVD increases with the duration of risk factor exposure [3].

The strengths of our study include the large nationwide sample of community-dwelling adults, the highly standardized measurements and the detailed questionnaires. The most important limitation is that severely ill and institutionalized men and women were mainly not included in the study which may have led to an underestimation of the risk factor proportions and to the rather low stroke and CHD prevalence. Equally important, the group without prior CHD or stroke includes individuals in all risk categories including high risk. It is a heterogeneous group which is not in the main focus of the paper. Therefore, the main finding is that uncontrolled risk factors are currently still highly prevalent both in the overall group (general population) and in the group with prior CHD or stroke, a clearly high-risk group likely to be aware of this high risk. A further limitation is the self-reported diagnosis of hypertension and dyslipidaemia which may have led to an underestimation of the prevalence of these diseases. However, information on prior diagnosis was used only to calculate awareness of elevated BP and elevated TC.

The risk factors in this analysis are all among the top risk factors contributing to the Global Burden of Disease both 1990 and 2010 [23]. It is never too late for improvements in behavioural risk factors, as illustrated by a 35 % reduction of CVD events in 4 years in adults aged 45 years and older who switched to a healthy lifestyle [2]. Clearly, to individuals and to treating physicians it may appear more intuitive to put effort into lifestyle changes and enrol in prevention interventions in high-risk situations [24] where the number-needed-to-treat to prevent an event is low. However, population benefits are larger if healthy lifestyles are adopted early on in order to prevent or delay hypertension, dyslipidaemia, obesity and chronic diseases [25, 26]. Action is required both at the health care system and societal level. Individuals may need treatment, but more often they need knowledge, motivation and accessible, convenient and attractive opportunities for improved lifestyle. For example, health education through mass media has been shown to be cost-effective to limit CVD [27]. The key to population-wide risk factor changes is clearly a combination of personal and non-personal interventions.

Conclusion

In conclusion, our study suggests that there is still a high prevention potential for adults in the general population and in the group with prior CHD or stroke in Germany and that prevention programs should aim at several major risk factors and their interrelations.

Abbreviations

ATC: 

Anatomical therapeutic chemical

BMI: 

Body mass index

BP: 

Blood pressure

CHD: 

Coronary heart disease

CVD: 

Cardiovascular disease

LDL: 

Low-density lipoprotein

TC: 

Total cholesterol

Declarations

Acknowledgements

DEGS1 is primarily funded by the German Ministry of Health (BMG).

Authors’ Affiliations

(1)
Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany
(2)
German Center for Cardiovascular Research (DZHK), Berlin, Germany
(3)
Department and Out-Patient Care of Neurology, Charité, Universitätsmedizin Berlin, Berlin, Germany
(4)
Center for Stroke Research Charité, Universitätsmedizin Berlin, Berlin, Germany
(5)
German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany

References

  1. European Heart Network and European Society of Cardiology. European Cardiovascular Disease Statistics. 2012.Google Scholar
  2. King DE, Mainous 3rd AG, Geesey ME. Turning back the clock: adopting a healthy lifestyle in middle age. Am J Med. 2007;120:598–603.View ArticlePubMedGoogle Scholar
  3. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635–701.View ArticlePubMedGoogle Scholar
  4. Banegas JR, Lopez-Garcia E, Dallongeville J, Guallar E, Halcox JP, Borghi C, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J. 2011;32:2143–52.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373:929–40.View ArticlePubMedGoogle Scholar
  6. Scheidt-Nave C, Kamtsiuris P, Gößwald A, Holling H, Lange M, Busch M, et al. German health interview and examination survey for adults (DEGS) - design, objectives and implementation of the first data collection wave. BMC Public Health. 2012;12:730.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Gößwald A, Lange M, Dölle R, Hölling H. The first wave of the German Health Interview and Examination Survey for Adults (DEGS1): Participant recruitment, fieldwork, and quality management. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:611–9.View ArticlePubMedGoogle Scholar
  8. Kamtsiuris P, Lange M, Hoffmann R, Schaffrath Rosario A, Dahm S, Kuhnert R, et al. The first wave of the German Health Interview and Examination Survey for Adults (DEGS1): Sample design, response, weighting and representativeness. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:620–30.View ArticlePubMedGoogle Scholar
  9. Krug S, Jordan S, Mensink GBM, Müters S, Finger J, Lampert T. Physical activity : Results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:765–71.View ArticlePubMedGoogle Scholar
  10. Burger M, Mensink GBM. High alcohol consumption in Germany: results of the German National Health Interview and Examination Survey 1998. Public Health Nutr. 2004;7:879–84.View ArticlePubMedGoogle Scholar
  11. Chang E, Canchola A, Lee V, Clarke C, Purdie D, Reynolds P, et al. Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort. Cancer Causes Control. 2007;18:91–103.View ArticlePubMedPubMed CentralGoogle Scholar
  12. WHO Global InfoBase team. The SuRF Report 2. Surveillance of chronic disease Risk Factors: Country-level data and comparable estimates. Geneva: World Health Organization; 2005.Google Scholar
  13. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421.Google Scholar
  14. King DE, Mainous 3rd AG, Carnemolla M, Everett CJ. Adherence to healthy lifestyle habits in US adults, 1988–2006. Am J Med. 2009;122:528–34.View ArticlePubMedGoogle Scholar
  15. Laccetti R, Pota A, Stranges S, Falconi C, Memoli B, Bardaro L, et al. Evidence on the prevalence and geographic distribution of major cardiovascular risk factors in Italy. Public Health Nutr. 2013;16:305–15.View ArticlePubMedGoogle Scholar
  16. Erdine S, Redon J, Bohm M, Ferri C, Kolloch R, Kreutz R, et al. Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey. Eur J Prev Cardiol. 2013;20:786–92.View ArticlePubMedGoogle Scholar
  17. Scheidt-Nave C, Du Y, Knopf H, Schienkiewitz A, Ziese T, Nowossadeck E, et al. Prevalence of dyslipidemia among adults in Germany : Results of the German health interview and examination survey for adults (DEGS 1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:661–7.View ArticlePubMedGoogle Scholar
  18. Robinson JG, Wang S, Smith BJ, Jacobson TA. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J Am Coll Cardiol. 2009;53:316–22.View ArticlePubMedGoogle Scholar
  19. Steinhagen-Thiessen E, Bramlage P, Losch C, Hauner H, Schunkert H, Vogt A, et al. Dyslipidemia in primary care–prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol. 2008;7:31.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Stranges S, Guallar E. Cardiovascular disease prevention in women: a rapidly evolving scenario. Nutr Metab Cardiovasc Dis. 2012;22:1013–8.View ArticlePubMedGoogle Scholar
  21. Tanuseputro P, Manuel DG, Leung M, Nguyen K, Johansen H, Canadian Cardiovascular Outcomes Research T. Risk factors for cardiovascular disease in Canada. Can J Cardiol. 2003;19:1249–59.PubMedGoogle Scholar
  22. Courtenay WH. Constructions of masculinity and their influence on men’s well-being: a theory of gender and health. Soc Sci Med. 2000;50:1385–401.View ArticlePubMedGoogle Scholar
  23. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369:448–57.View ArticlePubMedGoogle Scholar
  24. van Wyk JT, van Wijk MA, Sturkenboom MC, Moorman PW, van der Lei J. Identification of the four conventional cardiovascular disease risk factors by Dutch general practitioners. Chest. 2005;128:2521–7.View ArticlePubMedGoogle Scholar
  25. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed). 1981;282:1847–51.View ArticleGoogle Scholar
  26. Rose G. Sick individuals and sick populations. Int J Epidemiol. 2001;30:427–32.View ArticlePubMedGoogle Scholar
  27. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet. 2003;361:717–25.View ArticlePubMedGoogle Scholar

Copyright

© Truthmann et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement

BMC Public Health

ISSN: 1471-2458

Contact us